Search Clinical Trials
By Condition
By Location (USA)
By Location (Other)
By Sponsor
Resources
Privacy Policy
About Us
Disclaimer
Phase II Study of Pallidotomy for Parkinson Disease Clinical Trials References presented on Clinical Trials Search isn't meant to be a substitute for proven healthcare advice, trips or professional assistance using a genuine physician. We are not docs. Always confer with your physician about Phase II Study of Pallidotomy for Parkinson Disease conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. Phase II Study of Pallidotomy for Parkinson Disease Clinical research trials and Phase II Study of Pallidotomy for Parkinson Disease healthcare trials happen in hundreds of localities throughout the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the potency of new drugs. The propose of the studies / projects is to answer particular human health questions. Clinical trials are a popular way for mDs, government agencies, and private sector companies to detect cures for all sorts of conditions, such as Phase II Study of Pallidotomy for Parkinson Disease. Phase II Study of Pallidotomy for Parkinson Disease Clinical Trials and other clinical trials allow volunteers to acquire healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for free, and every now and again they are compensated for their time. Sometimes there is a cost for a Phase II Study of Pallidotomy for Parkinson Disease clinical trial. Subjects frequently obtain the most expert healthcare possible for their Phase II Study of Pallidotomy for Parkinson Disease condition. Risks are a reality, nevertheless, and can include more or frequent doctor trips, medical risks (possibly life-threatening), and/or the treatment being uneffective. Trials are federally governed with stern guidelines to protect clinical trials patients.

Home > "P" Clinical Trials Conditions > Phase II Study of Pallidotomy for Parkinson Disease

Phase II Study of Pallidotomy for Parkinson Disease



Phase II Study of Pallidotomy for Parkinson Disease

For Condition: Parkinson Disease
Status: Completed
Sponsor(s): National Center for Research Resources (NCRR) , Emory University
Synopsis: OBJECTIVES: I. Evaluate the safety and efficacy of pallidotomy immediately following 3 preoperative assessments vs. delayed pallidotomy following 6 months of standard medical therapy in patients with Parkinson disease.
Details: PROTOCOL OUTLINE: This is a randomized study. One group of patients undergoes the surgical procedure pallidotomy, a precise lesioning of brain cells in the globus pallidus. The other group receives standard medical care for 6 months followed by a pallidotomy.
Eligibility:
Study Type:
  Interventional, Treatment, Randomized
Minimum Age/Maximum Age: 30 Years/75 Years
Genders: Both
Protocol Entry Criteria: PROTOCOL ENTRY CRITERIA: --Disease Characteristics-- Idiopathic Parkinson disease Hoehn and Yahr stage III or worse during "off" periods Responsive to levodopa by history or exam Sub-optimal clinical response to maximal medication Medication optimized for at least 4 weeks prior to entry No atypical or secondary disease, e.g.: - No history of cerebrovascular accident - No cerebellar involvement - No severe brain atrophy on magnetic resonance imaging No Mattis Dementia Rating Scale score less than 116 No dementia meeting Diagnostic and Statistical Manual of Mental Disorders-IV criteria No Hamilton Depression Rating Scale score greater than 10 No Hamilton Anxiety Scale score greater than 14 --Patient Characteristics-- Other: No medical contraindication to surgery, e.g.: - Diabetes - Cardiopulmonary disease
Total Enrollment: 60

Location and Contact Information:

Overall Study Official:
MahlonDeLong,  Study Chair,  Emory University


Additional Information:
Study ID Numbers:
  199/12083;  EUSM-018,EUSM-409-92
Study Start Date: October 1994
Record last reviewed: December 2001
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00004670

Other Parkinson Disease Studies:
1. Phase II Study of Pallidotomy for Parkinson Disease

2. Intravenous Levodopa for the Diagnosis of Parkinson's Disease

3. Single Photon Emission Computed Tomography to Study Receptors in Parkinson's Disease

4. Donepezil to Treat Dementia in Parkinson's Disease

5. Molecular Epidemiology of Parkinson's Disease

Related Studies:

Other Parkinson Disease Clinical Trials
Other Clinical Trials
Other Clinical Trials

Phase II Study of Pallidotomy for Parkinson Disease

Modify your Search

  Other Parkinson Disease Clinical Trials
  Other Clinical Trials
  Other Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103